Composition and method to inhibit tissue plasminogen activator (tPA) -potentiated neurotoxicity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Feb 14, 2008
app pub date -
Aug 14, 2006
filing date -
Aug 14, 2006
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The present invention relates to methods of treating, preventing or ameliorating ischemia-related, neural cell degeneration in a subject being treated with a thrombolytic agent, by administering to the subject one or more neuroprotective thiosemicarbazone compounds. More particularly, the present invention relates to methods of preventing, treating or ameliorating the adverse neurological side effects of tissue plasminogen activator, which is used in the treatment of ischemic stroke, by co-administering one or more compounds of the present invention. One such neuroprotective compound is PAN-811. The invention also relates to compositions comprising PAN-811 or analogs thereof in admixture with a thrombolytic agent, such as tPA.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully